Products Affected - Description

• • Phenylephrine ophthalmic drops, Bausch Health, 10%, 5 mL bottle, 1 count, NDC 42702-0103-05
  • Phenylephrine ophthalmic drops, Bausch Health, 2.5%, 10 mL bottle, 1 count, NDC 42702-0102-10
  • Phenylephrine ophthalmic drops, Lifestar Pharma, LLC, 10%, 5 mL bottle, 1 count, NDC 70756-0612-30
  • Phenylephrine ophthalmic drops, Lifestar Pharma, LLC, 2.5%, 2 mL bottle, 1 count, NDC 70756-0629-25

Reason for the Shortage

• • Akorn ceased operations in February 2023.
  • Lifestar has phenylephrine ophthalmic solution on shortage due to increased demand.
  • Sandoz is no longer marketing phenylephrine ophthalmic solution.

Available Products

• • There is insufficient supply for usual ordering

• • Bausch Health has 10% phenylephrine 5 mL bottles on back order and the company estimates a release date of early-July 2023. There are short-dated 2.5% phenylephrine 10 mL bottles available with an expiration date of April 2024.
  • Lifestar has 2.5% phenylephrine 2 mL bottles and 10% phenylephrine 5 mL bottles on back order and the company estimates a release date of early-June 2023.